A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Osteoporosis
Interventions
DRUG

zoledronic acid

Trial Locations (18)

10993

Helen Hayes Hospital - Regional Bone Clinic, West Haverstraw

20902

The Center for Rheumatology and Bone Research, Wheaton

24901

Valley Medical Associates, Lewisburg

32605

Florida Medical Research Institute, Gainesville

35294

Univ. of Alabama/Division of Clinical Immunology and Rheumatology, Birmingham

38305

The Arthritis Clinic of Jackson, Jackson

44143

Private Practice, Mayfield Village

59101

Deaconess Billings Clinic Research Division, Billings

60611

Northwestern Center for Clinical Research, Chicago

65807

St. John's Medical Research, Springfield

75235

Radiant Research, Dallas

76107

Univ. of North Texas Health Science Center at Fort Worth, Fort Worth

77030

St. Luke's Episcopal Hospital Ctr for Ortho. Res. and Education, Houston

80230

Denver Arthritis Clinic, Denver

84117

Women's Health Center, Salt Lake City

92108

Radiant Research, San Diego

49048-1634

Midwest Arthritis Center, Kalamazoo

08903

UMDNJ-Robert Wood Johnson Medical School, New Brunswick

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY